Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pordy, Robert
159  Ergebnisse:
Personensuche X
?
1

Safety of the PCSK9 inhibitor alirocumab: insights from 47 ..:

Goodman, Shaun G ; Steg, Philippe Gabriel ; Szarek, Michael...
European Heart Journal - Cardiovascular Pharmacotherapy.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Alirocumab and cardiovascular outcomes according to sex and..:

Bittner, Vera A. ; Schwartz, Gregory G. ; Bhatt, Deepak L....
Journal of Clinical Lipidology.  , 2024
Link: https://doi.org/10.1016/..
 
?
3

Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patien..:

Rosenson, Robert S. ; Rader, Daniel J. ; Ali, Shazia...
Cardiovascular Drugs and Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

Evinacumab: Mechanism of action, clinical, and translationa..:

Dingman, Robert ; Bihorel, Sébastien ; Gusarova, Viktoria..
Clinical and Translational Science.  17 (2024)  6 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
5

Evinacumab for Pediatric Patients With Homozygous Familial ..:

Wiegman, Albert ; Greber-Platzer, Susanne ; Ali, Shazia...
Circulation.  149 (2024)  5 - p. 343-353 , 2024
Link: https://doi.org/10.1161/..
 
?
6

Evinacumab in homozygous familial hypercholesterolaemia: lo..:

Gaudet, Daniel ; Greber-Platzer, Susanne ; Reeskamp, Laurens F...
European Heart Journal.  , 2024
Link: https://doi.org/10.1093/..
 
?
7

THE IMPACT OF EVINACUMAB THERAPY ON PEDIATRIC PATIENTS WITH..:

Wiegman, Albert ; Greber-Platzer, Susanne ; Ali, Shazia...
American Journal of Preventive Cardiology.  15 (2023)  - p. 100545 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Transiently achieved very low LDL-cholesterol levels by sta..:

Schwartz, Gregory G ; Szarek, Michael ; Bhatt, Deepak L...
European Heart Journal.  , 2023
Link: https://doi.org/10.1093/..
 
?
9

Lipoprotein(a) and the Effect of Alirocumab on Revasculariz..:

Steg, P. Gabriel ; Szarek, Michael ; Valgimigli, Marco...
Canadian Journal of Cardiology.  39 (2023)  10 - p. 1315-1324 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Evinacumab Reduces US Apheresis Eligibility in Patients wit..:

Raal, Fredrick J ; McGinniss, Jennifer ; Pordy, Robert...
Journal of Clinical Lipidology.  17 (2023)  4 - p. e44 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Effect of alirocumab on cataracts in patients with acute co..:

Suc, Gaspard ; Schwartz, Gregory G. ; Goodman, Shaun G....
BMC Ophthalmology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
12

Evinacumab in severe hypertriglyceridemia with or without l..:

Rosenson, Robert S. ; Gaudet, Daniel ; Ballantyne, Christie M....
Nature Medicine.  29 (2023)  3 - p. 729-737 , 2023
Link: https://doi.org/10.1038/..
 
?
13

The Long-Term Efficacy and Safety of Evinacumab in Patients..:

Raal, Frederick J. ; Rosenson, Robert S. ; Reeskamp, Laurens F....
JACC: Advances.  2 (2023)  9 - p. 100648 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Correction: Effect of alirocumab on cataracts in patients w..:

Suc, Gaspard ; Schwartz, Gregory G. ; Goodman, Shaun G....
BMC Ophthalmology.  23 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
15

Effect of proprotein convertase subtilisin/kexin type 9 inh..:

Mohammadi, Kusha A. ; Brackin, Taylor ; Schwartz, Gregory G....
Cancer Medicine.  12 (2023)  16 - p. 16859-16868 , 2023
Link: https://doi.org/10.1002/..
 
1-15